Stem Cell IV Therapy: What an Infusion Can and Cannot Do

What is stem cell IV therapy, and does it work? Stem cell IV therapy is an infusion of cells, usually mesenchymal stem cells, into a vein through a drip, so they circulate through the whole body instead of being placed in one joint. Reviews of randomized trials show intravenous mesenchymal cells have a favorable short-term safety profile, but whether they help depends on the goal: there is early trial data for aging frailty and inflammation, while for knee, hip or back pain the studied route is a local injection, and the evidence for an IV drip alone is limited. It is not FDA-approved for these uses.

How a stem cell IV drip works

The cells are suspended in a sterile solution and infused through a vein in the arm, much like any other IV drip. From there they travel with the blood, and the first organ they reach is the lungs. In an animal study of intravenous delivery, the majority of mesenchymal stem cells were trapped in the lungs on their first pass, and the authors described the number reaching the arterial circulation as “therapeutically questionable” (Fischer et al., 2009).

That finding is why researchers study IV stem cells mainly for whole-body effects, such as signals that act on inflammation and the immune system, rather than expecting the cells to travel to a damaged knee and rebuild it. It is also why a drip and a joint injection are not interchangeable. If you want the mechanics in more depth, our guide on what full-body stem cell therapy does inside your body walks through it.

Is intravenous stem cell therapy safe?

The best safety data comes from controlled trials. An updated systematic review pooled 55 randomized trials with 2,696 adult patients who received mesenchymal cells into the bloodstream. Compared with controls, the cells were linked to more fever, but not to more infusion reactions, infections, clotting events, deaths or cancers, and no trial was stopped early for safety reasons (Thompson et al., 2020).

Two caveats matter. Those trials used characterized cell products under research protocols, and the FDA has received reports of blindness, tumor formation and infections linked to unapproved regenerative products marketed outside that kind of oversight (FDA). Safety depends on the product and the clinic, not on the word “stem cell”. Before any infusion, ask where the cells are processed and for the lab’s INVIMA certification; our page on how stem cell therapy is regulated in Colombia explains what to check.

Does a stem cell IV help? What the evidence shows by goal

“Stem cell IV benefits” lists online tend to mix conditions with very different evidence. Here is a fairer split:

Goal	Route studied most	What the evidence says
Knee or hip osteoarthritis	Injection into the joint	Of 43 clinical trials of MSC injections for osteoarthritis, most reported improvement, but the reviewers judged the results equivocal because of inconsistent methods. IV-only data is mostly from animal studies.
Aging frailty	IV infusion	A phase II trial in 30 older adults found IV cells safe at one month; the lower-dose group improved walking distance and inflammation markers versus placebo. Small, early data.
General inflammation, “wellness”	IV infusion	Safety data is reassuring in trials; benefit for healthy people has not been established.
Disc or spine pain	Injection into or near the disc	Evidence is early and mostly from small studies; it is not an IV indication.

So when someone asks “does stem cell injection work?”, the honest answer is: for joint pain, a targeted injection has the most data, and even that data is still being sorted out (systematic review, 2024). For aging frailty, a randomized trial of IV cells reported better walking and lower inflammatory markers in one dose group (Tompkins et al., 2017), but larger trials are still needed.

When a drip is the wrong tool

An IV infusion will not fix a mechanical problem. Surgery or another established treatment is usually the better choice if you have:

• A complete tendon or ligament tear with instability, or a retracted rotator cuff tear
• Nerve compression with progressive weakness, numbness or loss of bladder or bowel control (an emergency)
• Advanced joint collapse or deformity where joint replacement is the standard of care
• Active infection, active cancer, or a condition your own physician has not yet diagnosed

Our guide to who is not a candidate for stem cell therapy covers this in more detail.

Where stem cell IV therapy fits at our clinic

Systemic IV application is the basis of our full-body regeneration protocol, one of three protocols described on our stem cell therapy protocols page. It is aimed at adults who want a whole-body, anti-inflammatory approach and understand that the evidence is early. If your main problem is one painful joint, Dr. Catalina Henao will usually discuss a targeted protocol instead of, or alongside, an IV. Longevity-focused patients can read about our longevity and anti-aging program.

Pricing is per cell dose, set in Colombian pesos and converted to US dollars every Monday. For example, a 50 million cell dose is about USD 4,725 and a 100 million cell dose about USD 7,875. Flights and lodging are separate. Full table (exchange rate of October 19, 2026):

Stem cell dose	Price in USD	Price in Colombian pesos (COP)
10 million cells	USD 2,362	COP $7,500,000
25 million cells	USD 3,402	COP $10,800,000
50 million cells	USD 4,725	COP $15,000,000
100 million cells	USD 7,875	COP $25,000,000
150 million cells	USD 10,080	COP $32,000,000

Most patients stay five to seven days in Medellín, and our bilingual team follows up remotely after you return home. More detail on what drives the price is in our stem cell therapy cost guide.

Next step

If you are weighing a stem cell IV, send us your medical history and any recent imaging. Dr. Henao reviews your case at no cost and tells you whether an infusion, a targeted protocol or neither makes sense, and you get a written quote before you buy flights. Request your free case review.

Frequently asked questions

Is stem cell IV therapy FDA approved?

No. The FDA states that regenerative medicine therapies have not been approved to treat chronic pain or fatigue, and stem cell IV therapy for joint pain, aging or wellness is not FDA-approved. Our guide on FDA approval and stem cell therapy explains what that means for US patients.

Is an IV drip or a joint injection better for knee pain?

For knee osteoarthritis, the clinical trials mostly test injections into the joint. An IV drip sends most cells to the lungs first, so it is not the studied route for a single painful knee.

What are the side effects of intravenous stem cells?

In a review of 55 randomized trials, the main difference versus controls was a higher risk of fever. Infections, clotting events, deaths and cancers were not increased. Unregulated products carry additional risks, so product quality and lab certification matter.

How much does a stem cell IV cost in Medellín?

It depends on the cell dose. Prices are set in Colombian pesos and converted to US dollars every Monday; the dose table on this page shows the current figures, and you receive a written quote after the free case review. Flights and lodging are not included.

Is there stem cell IV therapy near me in the US?

Because these infusions are not FDA-approved for joint pain or aging, legitimate access in the US is mainly through registered clinical trials. The ISSCR patient guide explains how clinical trials work and offers resources to help you judge any clinic, at home or abroad.

Sources

• Fischer UM et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009.
• Thompson M et al. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis. EClinicalMedicine. 2020.
• Tompkins BA et al. Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci. 2017.
• Mesenchymal stem cell injections for the treatment of osteoarthritis: a systematic review of clinical trials. Acta Orthop Belg. 2024.
• U.S. Food and Drug Administration. Important patient and consumer information about regenerative medicine therapies.
• International Society for Stem Cell Research. The ISSCR guide to stem cell treatments.